| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| S9083 |
Global fee urgent care centers |
56,975 |
55,955 |
$7.06M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,189 |
2,189 |
$138K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,127 |
2,113 |
$107K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
468 |
467 |
$42K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,551 |
1,551 |
$24K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
618 |
606 |
$7K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
928 |
921 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
765 |
398 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
60 |
60 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
156 |
156 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
639 |
636 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
52 |
52 |
$1K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
140 |
138 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
26 |
25 |
$1K |
| 87081 |
|
329 |
329 |
$607.46 |
| 73110 |
|
12 |
12 |
$257.18 |
| 73630 |
|
13 |
12 |
$20.32 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
24 |
24 |
$16.30 |
| 81003 |
|
26 |
26 |
$7.74 |
| 99000 |
|
1,661 |
1,647 |
$0.00 |